Reviewed 15 cases. Clinical trial enrollment options explored for eligible patients.

Reviewed 15 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 11 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 6 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 15 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 10 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 15 cases. Supportive care needs and toxicity management addressed.

Reviewed 9 cases. Supportive care needs and toxicity management addressed.

Reviewed 15 cases. Supportive care needs and toxicity management addressed.

Reviewed 11 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 10 cases. Supportive care needs and toxicity management addressed.

Reviewed 6 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 6 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 5 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 9 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 14 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 6 cases. Radiation therapy field and dose adjustments recommended.

Reviewed 13 cases. Radiation therapy field and dose adjustments recommended.

Reviewed 9 cases. Clinical trial enrollment options explored for eligible patients.

Reviewed 7 cases. Pathology re-review prompted reclassification in two patients.

Reviewed 9 cases. Radiation therapy field and dose adjustments recommended.

Reviewed 9 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 11 cases. Pathology re-review prompted reclassification in two patients.

Reviewed 9 cases. Pathology re-review prompted reclassification in two patients.

Reviewed 7 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 13 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 8 cases. Clinical trial enrollment options explored for eligible patients.

Reviewed 15 cases. Imaging surveillance protocols updated per new NCCN guidelines.